Kevin J. Bitterman, Ph.D. is a Principal at Polaris Venture Partners. Kevin joined Polaris in 2004 and focuses on investments in the life sciences. Prior to joining Polaris, Kevin completed his Ph.D. in genetics at Harvard Medical School. His...

Affiliation: Unaffiliated

Sirtris Pharmaceuticals Co-founder
Genocea Biosciences Co-founder
TARIS Biomedical Director
Polaris Venture Partners Ph.D
Biolex Therapeutics Director
Genocea Biosciences Director
Solace Therapeutics Director
Polaris Partners Principal
Parasol Therapeutics Co-founder
Follica Director
Parasol Therapeutics Director
Pulmatrix Board Observer
Past